• Explore /
  • Poster
  • / Impact of HER2 mutation status on personalized molecular targeted therapy in advanced breast cancers.

Impact of HER2 mutation status on personalized molecular targeted therapy in advanced breast cancers.

Abstract Poster

Authors

null

Zongbi Yi

Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China

Zongbi Yi , Fei Ma , Yanfang Guan , Lianpeng Chang , Wenna Wang , Xiuwen Guan , Binliang Liu , Lixi Li , Chunxiao Li , Haili Qian , Venkataprasanth P. Reddy , Binghe Xu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

HER2-Positive

Citation

J Clin Oncol 36, 2018 (suppl; abstr 1039)

DOI

10.1200/JCO.2018.36.15_suppl.1039

Abstract #

1039

Poster Bd #

120

Abstract Disclosures

Similar Posters

First Author: Christian M. Kurbacher

First Author: Akihiko Shimomura

First Author: Elad Hikri

First Author: Julien Mazières